Strata Skin Sciences with ticker code (SSKN) have now 3 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 5 and 3 calculating the average target price we see 3.92. With the stocks previous close at 1.47 this would indicate that there is a potential upside of 166.7%. The 50 day MA is 1.51 and the 200 day MA is 1.39. The market capitalisation for the company is $47m. Visit the company website at: http://www.strataskinsciences.com
STRATA Skin Sciences, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences was founded in 1989 and is based in Horsham, Pennsylvania.